Methimazole

Generic name: Pronounced as (meth im' a zole)
Brand names
  • Tapazole®
Click on drug name to hear pronunciation

Medical Content Reviewed By HelloPharmacist Staff

Last Revised - 07/15/2017

Methimazole is used to treat hyperthyroidism, a condition that occurs when the thyroid gland produces too much thyroid hormone. It is also taken before thyroid surgery or radioactive iodine therapy.

This medication is sometimes prescribed for other uses; ask your doctor or pharmacist for more information.

Methimazole comes as a tablet and usually is taken three times a day, approximately every 8 hours, with food. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand.

Before taking methimazole,

  • tell your doctor and pharmacist if you are allergic to methimazol, lactose, or any other drugs.

  • tell your doctor and pharmacist what prescription and nonprescription medications you are taking, especially anticoagulants ('blood thinners') such as warfarin (Coumadin), beta blockers such as propranolol (Inderal), diabetes medications, digoxin (Lanoxin), theophylline (Theobid, Theo-Dur), and vitamins.

  • tell your doctor if you have or have ever had any blood disease, such as decreased white blood cells (leukopenia), decreased platelets (thrombocytopenia), or aplastic anemia, or liver disease (hepatitis, jaundice).

  • tell your doctor if you are pregnant, plan to become pregnant, or are breast-feeding. Methimazole should not be used during pregnancy or breast-feeding. If you become pregnant while taking methimazole, call your doctor immediately. Methimazole may harm the fetus.

  • if you are having surgery, including dental surgery, tell the doctor or dentist that you are taking methimazole.

Methimazole may cause an upset stomach. Take methimazole with food or milk.

Take the missed dose as soon as you remember it. However, if it is almost time for the next dose, skip the missed dose and continue your regular dosing schedule at evenly spaced, 8-hour intervals. Do not take a double dose to make up for a missed one.

  • Methimazole may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:

    • skin rash

    • itching

    • abnormal hair loss

    • upset stomach

    • vomiting

    • loss of taste

    • abnormal sensations (tingling, prickling, burning, tightness, and pulling)

    • swelling

    • joint and muscle pain

    • drowsiness

    • dizziness

    • decreased white blood cells

    • decreased platelets

  • If you experience any of the following symptoms, call your doctor immediately:

    • sore throat

    • fever

    • headache

    • chills

    • unusual bleeding or bruising

    • right-sided abdominal pain with decreased appetite

    • yellowing of the skin or eyes

    • skin eruptions

  • If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online (http://www.fda.gov/Safety/MedWatch) or by phone (1-800-332-1088).

Keep this medication in the container it came in, tightly closed, and out of reach of children. Store it at room temperature and away from excess heat and moisture (not in the bathroom).

Unneeded medications should be disposed of in special ways to ensure that pets, children, and other people cannot consume them. However, you should not flush this medication down the toilet. Instead, the best way to dispose of your medication is through a medicine take-back program. Talk to your pharmacist or contact your local garbage/recycling department to learn about take-back programs in your community. See the FDA's Safe Disposal of Medicines website (http://goo.gl/c4Rm4p) for more information if you do not have access to a take-back program.

It is important to keep all medication out of sight and reach of children as many containers (such as weekly pill minders and those for eye drops, creams, patches, and inhalers) are not child-resistant and young children can open them easily. To protect young children from poisoning, always lock safety caps and immediately place the medication in a safe location – one that is up and away and out of their sight and reach. http://www.upandaway.org

In case of overdose, call the poison control helpline at 1-800-222-1222. Information is also available online at https://www.poisonhelp.org/help. If the victim has collapsed, had a seizure, has trouble breathing, or can't be awakened, immediately call emergency services at 911.

Keep all appointments with your doctor and the laboratory.

Do not let anyone else take your medication. Ask your pharmacist any questions you have about refilling your prescription.

It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.

Drug Interaction
Montelukast Montelukast The metabolism of Montelukast can be decreased when combined with Methimazole.
Leflunomide Leflunomide The risk or severity of adverse effects can be increased when Methimazole is combined with Leflunomide.
Delavirdine Delavirdine The metabolism of Delavirdine can be decreased when combined with Methimazole.
Nevirapine Nevirapine The metabolism of Nevirapine can be decreased when combined with Methimazole.
Atorvastatin Atorvastatin The metabolism of Atorvastatin can be decreased when combined with Methimazole.
Dolasetron Dolasetron The metabolism of Dolasetron can be decreased when combined with Methimazole.
Aminophylline Aminophylline Methimazole may decrease the excretion rate of Aminophylline which could result in a higher serum level.
Anagrelide Anagrelide The metabolism of Anagrelide can be decreased when combined with Methimazole.
Candesartan Candesartan The metabolism of Candesartan can be decreased when combined with Methimazole.
Cilostazol Cilostazol The serum concentration of Cilostazol can be increased when it is combined with Methimazole.
Clopidogrel Clopidogrel The metabolism of Clopidogrel can be decreased when combined with Methimazole.
Estrogen and Progestin (Oral Contraceptives) Estrogen and Progestin (Oral Contraceptives) The metabolism of Conjugated estrogens can be decreased when combined with Methimazole.
Fenofibrate Fenofibrate The metabolism of Fenofibrate can be decreased when combined with Methimazole.
Guanfacine Guanfacine The metabolism of Guanfacine can be decreased when combined with Methimazole.
Magnesium Hydroxide Magnesium Hydroxide Methimazole may decrease the excretion rate of Magnesium hydroxide which could result in a higher serum level.
Mycophenolate Mycophenolate The risk or severity of adverse effects can be increased when Methimazole is combined with Mycophenolic acid.
Olsalazine Olsalazine Olsalazine may decrease the excretion rate of Methimazole which could result in a higher serum level.
Penbutolol Penbutolol The excretion of Acebutolol can be decreased when combined with Methimazole.
Potassium Potassium Potassium may increase the excretion rate of Methimazole which could result in a lower serum level and potentially a reduction in efficacy.
Prednisone Prednisone Methimazole may increase the excretion rate of Prednisone which could result in a lower serum level and potentially a reduction in efficacy.
Ranitidine Ranitidine The metabolism of Ranitidine can be decreased when combined with Methimazole.
Reserpine Reserpine Reserpine may decrease the excretion rate of Methimazole which could result in a higher serum level.
Rizatriptan Rizatriptan Methimazole may decrease the excretion rate of Rizatriptan which could result in a higher serum level.
Sumatriptan Sumatriptan Sumatriptan may decrease the excretion rate of Methimazole which could result in a higher serum level.
Tacrolimus Tacrolimus The serum concentration of Tacrolimus can be increased when it is combined with Methimazole.
Tizanidine Tizanidine The metabolism of Tizanidine can be decreased when combined with Methimazole.
Triamcinolone Triamcinolone The metabolism of Methimazole can be decreased when combined with Triamcinolone.
Zolmitriptan Zolmitriptan The metabolism of Zolmitriptan can be decreased when combined with Methimazole.
Ampicillin Injection Ampicillin Injection Ampicillin may decrease the excretion rate of Methimazole which could result in a higher serum level.
Doxycycline Injection Doxycycline Injection Doxycycline may decrease the excretion rate of Methimazole which could result in a higher serum level.
Fluconazole Injection Fluconazole Injection Fluconazole may decrease the excretion rate of Methimazole which could result in a higher serum level.
Foscarnet Injection Foscarnet Injection Foscarnet may decrease the excretion rate of Methimazole which could result in a higher serum level.
Hydromorphone Injection Hydromorphone Injection The metabolism of Hydromorphone can be decreased when combined with Methimazole.
Interferon Beta-1b Injection Interferon Beta-1b Injection The risk or severity of adverse effects can be increased when Interferon beta-1b is combined with Methimazole.
Interferon Gamma-1b Injection Interferon Gamma-1b Injection The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Methimazole.
Levofloxacin Injection Levofloxacin Injection Methimazole may decrease the excretion rate of Levofloxacin which could result in a higher serum level.
Meperidine Injection Meperidine Injection The metabolism of Meperidine can be decreased when combined with Methimazole.
Methylprednisolone Injection Methylprednisolone Injection The metabolism of Methylprednisolone can be decreased when combined with Methimazole.
Metoclopramide Injection Metoclopramide Injection The metabolism of Metoclopramide can be decreased when combined with Methimazole.
Metronidazole Injection Metronidazole Injection The metabolism of Metronidazole can be decreased when combined with Methimazole.
Pamidronate Injection Pamidronate Injection Pamidronic acid may decrease the excretion rate of Methimazole which could result in a higher serum level.
Vancomycin Injection Vancomycin Injection Methimazole may decrease the excretion rate of Vancomycin which could result in a higher serum level.
Zidovudine Injection Zidovudine Injection The risk or severity of adverse effects can be increased when Zidovudine is combined with Methimazole.
Altretamine Altretamine The metabolism of Methimazole can be decreased when combined with Amphetamine.
Cefuroxime Cefuroxime Cefuroxime may decrease the excretion rate of Methimazole which could result in a higher serum level.
Cyclosporine Cyclosporine Methimazole may increase the immunosuppressive activities of Cyclosporine.
Ondansetron Ondansetron The metabolism of Ondansetron can be decreased when combined with Methimazole.
Enoxaparin Injection Enoxaparin Injection Methimazole may increase the anticoagulant activities of Enoxaparin.
Torsemide Torsemide The metabolism of Torasemide can be decreased when combined with Methimazole.
Olanzapine Olanzapine The metabolism of Olanzapine can be decreased when combined with Methimazole.
Alosetron Alosetron The metabolism of Alosetron can be decreased when combined with Methimazole.
Dofetilide Dofetilide The metabolism of Dofetilide can be decreased when combined with Methimazole.
Hydroxychloroquine Hydroxychloroquine The risk or severity of adverse effects can be increased when Methimazole is combined with Hydroxychloroquine.
Meloxicam Meloxicam The metabolism of Meloxicam can be decreased when combined with Methimazole.
Pantoprazole Pantoprazole The metabolism of Pantoprazole can be decreased when combined with Methimazole.
Temozolomide Temozolomide The risk or severity of adverse effects can be increased when Methimazole is combined with Temozolomide.
Zaleplon Zaleplon Methimazole may decrease the excretion rate of Zaleplon which could result in a higher serum level.
Anakinra Anakinra The risk or severity of adverse effects can be increased when Anakinra is combined with Methimazole.
Linezolid Linezolid The risk or severity of adverse effects can be increased when Linezolid is combined with Methimazole.
Pentosan Polysulfate Pentosan Polysulfate Methimazole may increase the anticoagulant activities of Pentosan polysulfate.
Trimipramine Trimipramine The risk or severity of Cardiac Arrhythmia can be increased when Methimazole is combined with Trimipramine.
Etanercept Injection Etanercept Injection The risk or severity of adverse effects can be increased when Etanercept is combined with Methimazole.
Perindopril Perindopril Methimazole may decrease the excretion rate of Perindopril which could result in a higher serum level.
Tenofovir Tenofovir The metabolism of Methimazole can be decreased when combined with Tenofovir.
Choline Magnesium Trisalicylate Choline Magnesium Trisalicylate Choline magnesium trisalicylate may decrease the excretion rate of Methimazole which could result in a higher serum level.
Sirolimus Sirolimus The metabolism of Sirolimus can be decreased when combined with Methimazole.
Epinephrine Injection Epinephrine Injection The risk or severity of adverse effects can be increased when Epinephrine is combined with Methimazole.
Epirubicin Epirubicin The risk or severity of adverse effects can be increased when Epirubicin is combined with Methimazole.
Eplerenone Eplerenone The metabolism of Methimazole can be decreased when combined with Eplerenone.
Escitalopram Escitalopram The metabolism of Escitalopram can be decreased when combined with Methimazole.
Zonisamide Zonisamide The metabolism of Zonisamide can be decreased when combined with Methimazole.
Adalimumab Injection Adalimumab Injection The risk or severity of adverse effects can be increased when Adalimumab is combined with Methimazole.
Aripiprazole Aripiprazole The metabolism of Aripiprazole can be decreased when combined with Methimazole.
Atomoxetine Atomoxetine The metabolism of Atomoxetine can be decreased when combined with Methimazole.
Glatiramer Injection Glatiramer Injection The risk or severity of adverse effects can be increased when Methimazole is combined with Glatiramer.
Atazanavir Atazanavir The metabolism of Atazanavir can be decreased when combined with Methimazole.
Almotriptan Almotriptan The metabolism of Almotriptan can be decreased when combined with Methimazole.
Eletriptan Eletriptan The metabolism of Eletriptan can be decreased when combined with Methimazole.
Rosuvastatin Rosuvastatin The metabolism of Rosuvastatin can be decreased when combined with Methimazole.
Vardenafil Vardenafil The metabolism of Vardenafil can be decreased when combined with Methimazole.
Alfuzosin Alfuzosin The metabolism of Alfuzosin can be decreased when combined with Methimazole.
Emtricitabine Emtricitabine Methimazole may decrease the excretion rate of Emtricitabine which could result in a higher serum level.
Memantine Memantine Methimazole may decrease the excretion rate of Memantine which could result in a higher serum level.
Tegaserod Tegaserod The metabolism of Tegaserod can be decreased when combined with Methimazole.
Tadalafil Tadalafil The serum concentration of Tadalafil can be increased when it is combined with Methimazole.
Frovatriptan Frovatriptan The metabolism of Frovatriptan can be decreased when combined with Methimazole.
Progesterone Progesterone The metabolism of Progesterone can be decreased when combined with Methimazole.
Apomorphine Injection Apomorphine Injection The metabolism of Apomorphine can be decreased when combined with Methimazole.
Infliximab Injection Infliximab Injection The risk or severity of adverse effects can be increased when Infliximab is combined with Methimazole.
Protriptyline Protriptyline The risk or severity of Cardiac Arrhythmia can be increased when Methimazole is combined with Protriptyline.
Duloxetine Duloxetine The metabolism of Duloxetine can be decreased when combined with Methimazole.
Norethindrone Norethindrone The metabolism of Norethisterone can be decreased when combined with Methimazole.
Tinidazole Tinidazole Methimazole may decrease the excretion rate of Tinidazole which could result in a higher serum level.
Bosentan Bosentan The metabolism of Bosentan can be decreased when combined with Methimazole.
Cefditoren Cefditoren Cefdinir may decrease the excretion rate of Methimazole which could result in a higher serum level.
Cinacalcet Cinacalcet The metabolism of Cinacalcet can be decreased when combined with Methimazole.
Natalizumab Injection Natalizumab Injection The risk or severity of adverse effects can be increased when Methimazole is combined with Natalizumab.
Cyanocobalamin Injection Cyanocobalamin Injection Hydroxocobalamin may decrease the excretion rate of Methimazole which could result in a higher serum level.
Erlotinib Erlotinib The metabolism of Erlotinib can be decreased when combined with Methimazole.
Eszopiclone Eszopiclone The serum concentration of Eszopiclone can be increased when it is combined with Methimazole.
Ganciclovir Ganciclovir Methimazole may decrease the excretion rate of Ganciclovir which could result in a higher serum level.
Palifermin Palifermin The therapeutic efficacy of Palifermin can be decreased when used in combination with Methimazole.
Ribavirin Ribavirin Methimazole may decrease the excretion rate of Ribavirin which could result in a higher serum level.
Solifenacin Solifenacin The metabolism of Solifenacin can be decreased when combined with Methimazole.
Valganciclovir Valganciclovir Methimazole may decrease the excretion rate of Valganciclovir which could result in a higher serum level.
Voriconazole Voriconazole The metabolism of Voriconazole can be decreased when combined with Methimazole.
Adefovir Adefovir Adefovir may decrease the excretion rate of Methimazole which could result in a higher serum level.
Dextroamphetamine Dextroamphetamine The metabolism of Methimazole can be decreased when combined with Amphetamine.
Entecavir Entecavir The metabolism of Entecavir can be decreased when combined with Methimazole.
Peginterferon Alfa-2a Injection Peginterferon Alfa-2a Injection The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Methimazole.
Peginterferon Alfa-2b (PEG-Intron) Peginterferon Alfa-2b (PEG-Intron) The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Methimazole.
Ramelteon Ramelteon The metabolism of Ramelteon can be decreased when combined with Methimazole.
Darifenacin Darifenacin The metabolism of Darifenacin can be decreased when combined with Methimazole.
Fentanyl Fentanyl The metabolism of Fentanyl can be decreased when combined with Methimazole.
Pregabalin Pregabalin Pregabalin may decrease the excretion rate of Methimazole which could result in a higher serum level.
Phenylephrine Phenylephrine The risk or severity of adverse effects can be increased when Phenylephrine is combined with Methimazole.
Tipranavir Tipranavir The metabolism of Tipranavir can be decreased when combined with Methimazole.
Felbamate Felbamate The metabolism of Felbamate can be decreased when combined with Methimazole.
Ranolazine Ranolazine The metabolism of Ranolazine can be decreased when combined with Methimazole.
Abatacept Injection Abatacept Injection The risk or severity of adverse effects can be increased when Methimazole is combined with Abatacept.
Rasagiline Rasagiline The metabolism of Rasagiline can be decreased when combined with Methimazole.
Imatinib Imatinib The therapeutic efficacy of Methimazole can be decreased when used in combination with Imatinib.
Sitagliptin Sitagliptin Methimazole may decrease the excretion rate of Sitagliptin which could result in a higher serum level.
Varenicline Varenicline Methimazole may decrease the excretion rate of Varenicline which could result in a higher serum level.
Bevacizumab Injection Bevacizumab Injection The risk or severity of adverse effects can be increased when Bevacizumab is combined with Methimazole.
Gefitinib Gefitinib The therapeutic efficacy of Gefitinib can be decreased when used in combination with Methimazole.
Albuterol Albuterol Methimazole may decrease the excretion rate of Salbutamol which could result in a higher serum level.
Paliperidone Paliperidone The metabolism of Paliperidone can be decreased when combined with Methimazole.
Bortezomib Bortezomib The metabolism of Methimazole can be decreased when combined with Bortezomib.
Clofarabine Injection Clofarabine Injection The risk or severity of adverse effects can be increased when Clofarabine is combined with Methimazole.
Hepatitis B Vaccine Hepatitis B Vaccine The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Methimazole.
Influenza Vaccine, Inactivated or Recombinant Influenza Vaccine, Inactivated or Recombinant The therapeutic efficacy of Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Methimazole.
Influenza Vaccine, Live Intranasal Influenza Vaccine, Live Intranasal The risk or severity of infection can be increased when Typhoid Vaccine Live is combined with Methimazole.
Live Shingles (Zoster) Vaccine (ZVL) Live Shingles (Zoster) Vaccine (ZVL) The risk or severity of infection can be increased when Varicella Zoster Vaccine (Live/attenuated) is combined with Methimazole.
Lubiprostone Lubiprostone Methimazole may decrease the excretion rate of Lubiprostone which could result in a higher serum level.
Oxaliplatin Injection Oxaliplatin Injection The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Methimazole.
Primaquine Primaquine The metabolism of Primaquine can be decreased when combined with Methimazole.
Rituximab Injection Rituximab Injection The risk or severity of adverse effects can be increased when Rituximab is combined with Methimazole.
Pemetrexed Injection Pemetrexed Injection The risk or severity of adverse effects can be increased when Pemetrexed is combined with Methimazole.
Lisdexamfetamine Lisdexamfetamine The risk or severity of adverse effects can be increased when Lisdexamfetamine is combined with Methimazole.
Retapamulin Retapamulin The metabolism of Retapamulin can be decreased when combined with Methimazole.
Vorinostat Vorinostat The risk or severity of adverse effects can be increased when Methimazole is combined with Vorinostat.
Sorafenib Sorafenib The therapeutic efficacy of Methimazole can be decreased when used in combination with Sorafenib.
Sunitinib Sunitinib The therapeutic efficacy of Sunitinib can be decreased when used in combination with Methimazole.
Dronabinol Dronabinol The metabolism of Dronabinol can be decreased when combined with Methimazole.
Lapatinib Lapatinib The metabolism of Lapatinib can be decreased when combined with Methimazole.
Levocetirizine Levocetirizine Methimazole may decrease the excretion rate of Levocetirizine which could result in a higher serum level.
Pegaptanib Injection Pegaptanib Injection Methimazole may decrease the excretion rate of Pegaptanib which could result in a higher serum level.
Dasatinib Dasatinib The metabolism of Dasatinib can be decreased when combined with Methimazole.
Mexiletine Mexiletine The metabolism of Mexiletine can be decreased when combined with Methimazole.
Azacitidine Injection Azacitidine Injection The risk or severity of adverse effects can be increased when Methimazole is combined with Azacitidine.
Temsirolimus Temsirolimus The metabolism of Temsirolimus can be decreased when combined with Methimazole.
Maraviroc Maraviroc The metabolism of Maraviroc can be decreased when combined with Methimazole.
Nelarabine Injection Nelarabine Injection The risk or severity of adverse effects can be increased when Methimazole is combined with Nelarabine.
Lenalidomide Lenalidomide The risk or severity of adverse effects can be increased when Lenalidomide is combined with Methimazole.
Nilotinib Nilotinib The metabolism of Nilotinib can be decreased when combined with Methimazole.
Bexarotene Bexarotene The risk or severity of adverse effects can be increased when Bexarotene is combined with Methimazole.
Budesonide Budesonide The metabolism of Budesonide can be decreased when combined with Methimazole.
Chloramphenicol Injection Chloramphenicol Injection The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Methimazole.
Decitabine Injection Decitabine Injection The risk or severity of adverse effects can be increased when Methimazole is combined with Decitabine.
Desmopressin Desmopressin Desmopressin may decrease the excretion rate of Methimazole which could result in a higher serum level.
Doripenem Injection Doripenem Injection Methimazole may decrease the excretion rate of Doripenem which could result in a higher serum level.
Etravirine Etravirine The metabolism of Etravirine can be decreased when combined with Methimazole.
Arsenic Trioxide Injection Arsenic Trioxide Injection The risk or severity of adverse effects can be increased when Methimazole is combined with Arsenic trioxide.
Mitoxantrone Injection Mitoxantrone Injection The risk or severity of adverse effects can be increased when Methimazole is combined with Mitoxantrone.
Desvenlafaxine Desvenlafaxine Desvenlafaxine may decrease the excretion rate of Methimazole which could result in a higher serum level.
Cevimeline Cevimeline The metabolism of Cevimeline can be decreased when combined with Methimazole.
Nebivolol Nebivolol The excretion of Nebivolol can be decreased when combined with Methimazole.
Tretinoin Tretinoin The risk or severity of adverse effects can be increased when Tretinoin is combined with Methimazole.
Bendamustine Injection Bendamustine Injection The risk or severity of adverse effects can be increased when Methimazole is combined with Bendamustine.
Flecainide Flecainide The metabolism of Flecainide can be decreased when combined with Methimazole.
Certolizumab Injection Certolizumab Injection The risk or severity of adverse effects can be increased when Methimazole is combined with Certolizumab pegol.
Ixabepilone Injection Ixabepilone Injection The metabolism of Ixabepilone can be decreased when combined with Methimazole.
Irinotecan Injection Irinotecan Injection The serum concentration of SN-38, an active metabolite of Methimazole, can be increased when used in combination with Irinotecan.
Daptomycin Injection Daptomycin Injection Daptomycin may decrease the excretion rate of Methimazole which could result in a higher serum level.
Estramustine Estramustine The risk or severity of adverse effects can be increased when Methimazole is combined with Estramustine.
Praziquantel Praziquantel The metabolism of Praziquantel can be decreased when combined with Methimazole.
Methylnaltrexone Injection Methylnaltrexone Injection Methimazole may decrease the excretion rate of Methylnaltrexone which could result in a higher serum level.
Alemtuzumab Injection (Chronic Lymphocytic Leukemia) Alemtuzumab Injection (Chronic Lymphocytic Leukemia) The risk or severity of adverse effects can be increased when Alemtuzumab is combined with Methimazole.
Rufinamide Rufinamide The metabolism of Rufinamide can be decreased when combined with Methimazole.
Midazolam Midazolam The serum concentration of Midazolam can be increased when it is combined with Methimazole.
Dexrazoxane Injection Dexrazoxane Injection The risk or severity of adverse effects can be increased when Dexrazoxane is combined with Methimazole.
Eltrombopag Eltrombopag The metabolism of Eltrombopag can be decreased when combined with Methimazole.
Ibritumomab Injection Ibritumomab Injection The risk or severity of adverse effects can be increased when Ibritumomab tiuxetan is combined with Methimazole.
Milnacipran Milnacipran The metabolism of Milnacipran can be decreased when combined with Methimazole.
Dexlansoprazole Dexlansoprazole The metabolism of Dexlansoprazole can be decreased when combined with Methimazole.
Plerixafor Injection Plerixafor Injection Methimazole may decrease the excretion rate of Plerixafor which could result in a higher serum level.
Fesoterodine Fesoterodine The metabolism of Fesoterodine can be decreased when combined with Methimazole.
Betaxolol Betaxolol The excretion of Betaxolol can be decreased when combined with Methimazole.
Iloperidone Iloperidone The metabolism of Iloperidone can be decreased when combined with Methimazole.
Prasugrel Prasugrel The metabolism of Prasugrel can be decreased when combined with Methimazole.
Lacosamide Lacosamide The metabolism of Lacosamide can be decreased when combined with Methimazole.
Everolimus Everolimus The metabolism of Everolimus can be decreased when combined with Methimazole.
Tolvaptan (low blood sodium) Tolvaptan (low blood sodium) The metabolism of Methimazole can be decreased when combined with Tolvaptan.
Dronedarone Dronedarone The metabolism of Dronedarone can be decreased when combined with Methimazole.
Pralatrexate Injection Pralatrexate Injection The risk or severity of adverse effects can be increased when Methimazole is combined with Pralatrexate.
Palonosetron Injection Palonosetron Injection The metabolism of Palonosetron can be decreased when combined with Methimazole.
Saxagliptin Saxagliptin The metabolism of Saxagliptin can be decreased when combined with Methimazole.
Telavancin Injection Telavancin Injection Methimazole may decrease the excretion rate of Telavancin which could result in a higher serum level.
Romidepsin Injection Romidepsin Injection The metabolism of Romidepsin can be decreased when combined with Methimazole.
Tapentadol Tapentadol The metabolism of Tapentadol can be decreased when combined with Methimazole.
Topotecan Topotecan The risk or severity of adverse effects can be increased when Methimazole is combined with Topotecan.
Golimumab Injection Golimumab Injection The risk or severity of adverse effects can be increased when Methimazole is combined with Golimumab.
Pazopanib Pazopanib The metabolism of Pazopanib can be decreased when combined with Methimazole.
Asenapine Asenapine The metabolism of Asenapine can be decreased when combined with Methimazole.
Pitavastatin Pitavastatin The metabolism of Pitavastatin can be decreased when combined with Methimazole.
Albendazole Albendazole The metabolism of Albendazole can be decreased when combined with Methimazole.
Oxymorphone Oxymorphone The metabolism of Oxymorphone can be decreased when combined with Methimazole.
Denosumab Injection Denosumab Injection The risk or severity of adverse effects can be increased when Denosumab is combined with Methimazole.
Dabigatran Dabigatran Methimazole may increase the anticoagulant activities of Dabigatran.
Tocilizumab Injection Tocilizumab Injection The risk or severity of adverse effects can be increased when Methimazole is combined with Tocilizumab.
Dalfampridine Dalfampridine Methimazole may decrease the excretion rate of Dalfampridine which could result in a higher serum level.
Fingolimod Fingolimod Methimazole may increase the immunosuppressive activities of Fingolimod.
Eribulin Injection Eribulin Injection The risk or severity of adverse effects can be increased when Methimazole is combined with Eribulin.
Cabazitaxel Injection Cabazitaxel Injection The metabolism of Cabazitaxel can be decreased when combined with Methimazole.
Ceftaroline Injection Ceftaroline Injection Ceftaroline fosamil may decrease the excretion rate of Methimazole which could result in a higher serum level.
Acetaminophen Injection Acetaminophen Injection Methimazole may increase the hepatotoxic activities of Acetaminophen.
Vilazodone Vilazodone The metabolism of Vilazodone can be decreased when combined with Methimazole.
Ipilimumab Injection Ipilimumab Injection Methimazole may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Denileukin Diftitox Injection Denileukin Diftitox Injection The therapeutic efficacy of Methimazole can be decreased when used in combination with Aldesleukin.
Sipuleucel-T Injection Sipuleucel-T Injection The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Methimazole.
Terbutaline Injection Terbutaline Injection The risk or severity of adverse effects can be increased when Methimazole is combined with Terbutaline.
Belimumab Injection Belimumab Injection The risk or severity of adverse effects can be increased when Methimazole is combined with Belimumab.
Busulfan Injection Busulfan Injection The metabolism of Busulfan can be decreased when combined with Methimazole.
Roflumilast Roflumilast Roflumilast may increase the immunosuppressive activities of Methimazole.
Linagliptin Linagliptin The metabolism of Linagliptin can be decreased when combined with Methimazole.
Cyclophosphamide Injection Cyclophosphamide Injection The metabolism of Methimazole can be decreased when combined with Cyclophosphamide.
Rivaroxaban Rivaroxaban Methimazole may increase the anticoagulant activities of Rivaroxaban.
Ticagrelor Ticagrelor Methimazole may increase the anticoagulant activities of Ticagrelor.
Brentuximab Vedotin Injection Brentuximab Vedotin Injection The metabolism of Brentuximab vedotin can be decreased when combined with Methimazole.
Ruxolitinib Ruxolitinib The metabolism of Ruxolitinib can be decreased when combined with Methimazole.
Vandetanib Vandetanib The therapeutic efficacy of Methimazole can be decreased when used in combination with Vandetanib.
Clobazam Clobazam The metabolism of Clobazam can be decreased when combined with Methimazole.
Vemurafenib Vemurafenib The therapeutic efficacy of Methimazole can be decreased when used in combination with Vemurafenib.
Vismodegib Vismodegib The metabolism of Vismodegib can be decreased when combined with Methimazole.
Belatacept Injection Belatacept Injection The risk or severity of adverse effects can be increased when Methimazole is combined with Belatacept.
Ivacaftor Ivacaftor The metabolism of Ivacaftor can be decreased when combined with Methimazole.
Basiliximab Injection Basiliximab Injection The risk or severity of adverse effects can be increased when Basiliximab is combined with Methimazole.
Deferiprone Deferiprone Methimazole may decrease the excretion rate of Deferiprone which could result in a higher serum level.
Axitinib Axitinib The metabolism of Axitinib can be decreased when combined with Methimazole.
Crizotinib Crizotinib The therapeutic efficacy of Methimazole can be decreased when used in combination with Crizotinib.
Melphalan Injection Melphalan Injection The risk or severity of adverse effects can be increased when Methimazole is combined with Melphalan.
Cabergoline Cabergoline The metabolism of Cabergoline can be decreased when combined with Methimazole.
Naloxone Injection Naloxone Injection Methimazole may decrease the excretion rate of Naloxone which could result in a higher serum level.
Eculizumab Injection Eculizumab Injection The risk or severity of adverse effects can be increased when Methimazole is combined with Eculizumab.
Fondaparinux Injection Fondaparinux Injection Fondaparinux may increase the anticoagulant activities of Methimazole.
Carfilzomib Injection Carfilzomib Injection The risk or severity of adverse effects can be increased when Methimazole is combined with Carfilzomib.
Iloprost Iloprost Methimazole may increase the anticoagulant activities of Iloprost.
Enzalutamide Enzalutamide The metabolism of Enzalutamide can be decreased when combined with Methimazole.
Mirabegron Mirabegron The metabolism of Mirabegron can be decreased when combined with Methimazole.
Regorafenib Regorafenib The therapeutic efficacy of Methimazole can be decreased when used in combination with Regorafenib.
Bosutinib Bosutinib The therapeutic efficacy of Bosutinib can be decreased when used in combination with Methimazole.
Corticotropin, Repository Injection Corticotropin, Repository Injection The metabolism of Corticotropin can be decreased when combined with Methimazole.
Teriflunomide Teriflunomide The risk or severity of adverse effects can be increased when Methimazole is combined with Teriflunomide.
Cabozantinib (thyroid cancer) Cabozantinib (thyroid cancer) The metabolism of Cabozantinib can be decreased when combined with Methimazole.
Teduglutide Injection Teduglutide Injection Methimazole may decrease the excretion rate of Teduglutide which could result in a higher serum level.
Bedaquiline Bedaquiline The metabolism of Bedaquiline can be decreased when combined with Methimazole.
Icosapent Ethyl Icosapent Ethyl The risk or severity of bleeding can be increased when Icosapent ethyl is combined with Methimazole.
Tofacitinib Tofacitinib The metabolism of Tofacitinib can be decreased when combined with Methimazole.
Alogliptin Alogliptin The metabolism of Alogliptin can be decreased when combined with Methimazole.
Dimethyl Fumarate Dimethyl Fumarate The risk or severity of adverse effects can be increased when Methimazole is combined with Dimethyl fumarate.
Ponatinib Ponatinib The metabolism of Ponatinib can be decreased when combined with Methimazole.
Pomalidomide Pomalidomide The metabolism of Pomalidomide can be decreased when combined with Methimazole.
Ado-trastuzumab Emtansine Injection Ado-trastuzumab Emtansine Injection The metabolism of Trastuzumab emtansine can be decreased when combined with Methimazole.
Apixaban Apixaban The metabolism of Apixaban can be decreased when combined with Methimazole.
Canagliflozin Canagliflozin Canagliflozin may increase the excretion rate of Methimazole which could result in a lower serum level and potentially a reduction in efficacy.
Methazolamide Methazolamide Methazolamide may increase the excretion rate of Methimazole which could result in a lower serum level and potentially a reduction in efficacy.
Dabrafenib Dabrafenib The metabolism of Dabrafenib can be decreased when combined with Methimazole.
Ospemifene Ospemifene The metabolism of Ospemifene can be decreased when combined with Methimazole.
Trametinib Trametinib Methimazole may decrease the excretion rate of Trametinib which could result in a higher serum level.
Afatinib Afatinib The therapeutic efficacy of Methimazole can be decreased when used in combination with Afatinib.
Levomilnacipran Levomilnacipran The metabolism of Levomilnacipran can be decreased when combined with Methimazole.
Ertapenem Injection Ertapenem Injection Ertapenem may decrease the excretion rate of Methimazole which could result in a higher serum level.
Vortioxetine Vortioxetine The metabolism of Vortioxetine can be decreased when combined with Methimazole.
Perampanel Perampanel The metabolism of Perampanel can be decreased when combined with Methimazole.
Ibrutinib Ibrutinib The metabolism of Ibrutinib can be decreased when combined with Methimazole.
Lomitapide Lomitapide The metabolism of Lomitapide can be decreased when combined with Methimazole.
Ketorolac Injection Ketorolac Injection Ketorolac may decrease the excretion rate of Methimazole which could result in a higher serum level.
Obinutuzumab Injection Obinutuzumab Injection The risk or severity of adverse effects can be increased when Methimazole is combined with Obinutuzumab.
Sofosbuvir Sofosbuvir Methimazole may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.
Dapagliflozin Dapagliflozin The metabolism of Dapagliflozin can be decreased when combined with Methimazole.
Apremilast Apremilast The risk or severity of adverse effects can be increased when Methimazole is combined with Apremilast.
Droxidopa Droxidopa Methimazole may decrease the excretion rate of Droxidopa which could result in a higher serum level.
Ceritinib Ceritinib The metabolism of Methimazole can be decreased when combined with Ceritinib.
Siltuximab Injection Siltuximab Injection The risk or severity of adverse effects can be increased when Methimazole is combined with Siltuximab.
Vedolizumab Injection Vedolizumab Injection The risk or severity of adverse effects can be increased when Methimazole is combined with Vedolizumab.
Belinostat Injection Belinostat Injection The risk or severity of adverse effects can be increased when Methimazole is combined with Belinostat.
Idelalisib Idelalisib The metabolism of Idelalisib can be decreased when combined with Methimazole.
Testosterone Injection Testosterone Injection The metabolism of Testosterone can be decreased when combined with Methimazole.
Vorapaxar Vorapaxar The metabolism of Vorapaxar can be decreased when combined with Methimazole.
Hydrocodone Hydrocodone The metabolism of Hydrocodone can be decreased when combined with Methimazole.
Suvorexant Suvorexant The metabolism of Suvorexant can be decreased when combined with Methimazole.
Edoxaban Edoxaban Methimazole may increase the anticoagulant activities of Edoxaban.
Peginterferon Beta-1a Injection Peginterferon Beta-1a Injection The risk or severity of adverse effects can be increased when Methimazole is combined with Peginterferon beta-1a.
Olaparib Olaparib The metabolism of Olaparib can be decreased when combined with Methimazole.
Blinatumomab Injection Blinatumomab Injection The risk or severity of adverse effects can be increased when Methimazole is combined with Blinatumomab.
Methamphetamine Methamphetamine The metabolism of Metamfetamine can be decreased when combined with Methimazole.
Tasimelteon Tasimelteon The metabolism of Tasimelteon can be decreased when combined with Methimazole.
Riociguat Riociguat The serum concentration of Riociguat can be increased when it is combined with Methimazole.
Pirfenidone Pirfenidone The risk or severity of adverse effects can be increased when Methimazole is combined with Pirfenidone.
Nintedanib Nintedanib The therapeutic efficacy of Methimazole can be decreased when used in combination with Nintedanib.
Secukinumab Injection Secukinumab Injection The risk or severity of adverse effects can be increased when Methimazole is combined with Secukinumab.
Risperidone Injection Risperidone Injection The metabolism of Risperidone can be decreased when combined with Methimazole.
Palbociclib Palbociclib The metabolism of Palbociclib can be decreased when combined with Methimazole.
Lenvatinib Lenvatinib The therapeutic efficacy of Methimazole can be decreased when used in combination with Lenvatinib.
Panobinostat Panobinostat The metabolism of Panobinostat can be decreased when combined with Methimazole.
Dinutuximab Injection Dinutuximab Injection The risk or severity of adverse effects can be increased when Methimazole is combined with Dinutuximab.
Haloperidol Injection Haloperidol Injection The serum concentration of Haloperidol can be increased when it is combined with Methimazole.
Amiloride Amiloride Amiloride may increase the excretion rate of Methimazole which could result in a lower serum level and potentially a reduction in efficacy.
Isavuconazonium Injection Isavuconazonium Injection The serum concentration of Isavuconazonium can be increased when it is combined with Methimazole.
Macitentan Macitentan Methimazole may decrease the excretion rate of Macitentan which could result in a higher serum level.
Sonidegib Sonidegib The metabolism of Sonidegib can be decreased when combined with Methimazole.
Flibanserin Flibanserin The metabolism of Flibanserin can be decreased when combined with Methimazole.
Prednisolone Prednisolone Methimazole may increase the excretion rate of Prednisolone which could result in a lower serum level and potentially a reduction in efficacy.
Daclatasvir Daclatasvir The metabolism of Daclatasvir can be decreased when combined with Methimazole.
Brexpiprazole Brexpiprazole The metabolism of Brexpiprazole can be decreased when combined with Methimazole.
Ziprasidone Injection Ziprasidone Injection The metabolism of Ziprasidone can be decreased when combined with Methimazole.
Cariprazine Cariprazine The metabolism of Cariprazine can be decreased when combined with Methimazole.
Penicillin G Procaine Injection Penicillin G Procaine Injection Methimazole may decrease the excretion rate of Procaine benzylpenicillin which could result in a higher serum level.
Cobimetinib Cobimetinib The metabolism of Cobimetinib can be decreased when combined with Methimazole.
Mepolizumab Injection Mepolizumab Injection The risk or severity of adverse effects can be increased when Methimazole is combined with Mepolizumab.
Trabectedin Injection Trabectedin Injection The metabolism of Trabectedin can be decreased when combined with Methimazole.
Osimertinib Osimertinib The metabolism of Methimazole can be decreased when combined with Osimertinib.
Alectinib Alectinib The therapeutic efficacy of Methimazole can be decreased when used in combination with Alectinib.
Ixazomib Ixazomib The metabolism of Ixazomib can be decreased when combined with Methimazole.
Lesinurad Lesinurad The metabolism of Lesinurad can be decreased when combined with Methimazole.
Amphotericin B Liposomal Injection Amphotericin B Liposomal Injection Amphotericin B may decrease the excretion rate of Methimazole which could result in a higher serum level.
Dexamethasone Injection Dexamethasone Injection The metabolism of Dexamethasone can be decreased when combined with Methimazole.
Defibrotide Injection Defibrotide Injection Methimazole may increase the anticoagulant activities of Defibrotide.
Ixekizumab Injection Ixekizumab Injection The risk or severity of adverse effects can be increased when Methimazole is combined with Ixekizumab.
Brivaracetam Injection Brivaracetam Injection The metabolism of Brivaracetam can be decreased when combined with Methimazole.
Venetoclax Venetoclax The metabolism of Venetoclax can be decreased when combined with Methimazole.
Midodrine Midodrine The risk or severity of adverse effects can be increased when Midodrine is combined with Methimazole.
Diphenhydramine Injection Diphenhydramine Injection The metabolism of Diphenhydramine can be decreased when combined with Methimazole.
Furosemide Injection Furosemide Injection Furosemide may increase the excretion rate of Methimazole which could result in a lower serum level and potentially a reduction in efficacy.
Rucaparib Rucaparib The metabolism of Rucaparib can be decreased when combined with Methimazole.
Lixisenatide Injection Lixisenatide Injection Methimazole may decrease the excretion rate of Lixisenatide which could result in a higher serum level.
Ribociclib Ribociclib The metabolism of Ribociclib can be decreased when combined with Methimazole.
Brodalumab Injection Brodalumab Injection The risk or severity of adverse effects can be increased when Methimazole is combined with Brodalumab.
Brigatinib Brigatinib The metabolism of Methimazole can be decreased when combined with Brigatinib.
Doxepin (Insomnia) Doxepin (Insomnia) The risk or severity of Cardiac Arrhythmia can be increased when Methimazole is combined with Doxepin.
Deutetrabenazine Deutetrabenazine The metabolism of Deutetrabenazine can be decreased when combined with Methimazole.
Valbenazine Valbenazine The metabolism of Valbenazine can be decreased when combined with Methimazole.
Deflazacort Deflazacort The serum concentration of Deflazacort can be increased when it is combined with Methimazole.
Ocrelizumab Injection Ocrelizumab Injection Methimazole may increase the immunosuppressive activities of Ocrelizumab.
Naldemedine Naldemedine Methimazole may decrease the excretion rate of Naldemedine which could result in a higher serum level.
Sarilumab Injection Sarilumab Injection The risk or severity of adverse effects can be increased when Methimazole is combined with Sarilumab.
Midostaurin Midostaurin The therapeutic efficacy of Methimazole can be decreased when used in combination with Midostaurin.
Neratinib Neratinib The serum concentration of Methimazole can be increased when it is combined with Neratinib.
Guselkumab Injection Guselkumab Injection The risk or severity of adverse effects can be increased when Methimazole is combined with Guselkumab.
Enasidenib Enasidenib The metabolism of Enasidenib can be decreased when combined with Methimazole.
Aprepitant/Fosaprepitant Injection Aprepitant/Fosaprepitant Injection The metabolism of Fosaprepitant can be decreased when combined with Methimazole.
Benznidazole Benznidazole Methimazole may decrease the excretion rate of Benznidazole which could result in a higher serum level.
Copanlisib Injection Copanlisib Injection The metabolism of Copanlisib can be decreased when combined with Methimazole.
Delafloxacin Delafloxacin Methimazole may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Abemaciclib Abemaciclib The metabolism of Abemaciclib can be decreased when combined with Methimazole.
Betrixaban Betrixaban Methimazole may increase the anticoagulant activities of Betrixaban.
Acalabrutinib Acalabrutinib The therapeutic efficacy of Methimazole can be decreased when used in combination with Acalabrutinib.
Gemtuzumab Ozogamicin Injection Gemtuzumab Ozogamicin Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Methimazole.
Letermovir Letermovir The metabolism of Letermovir can be decreased when combined with Methimazole.
Tetrabenazine Tetrabenazine The metabolism of Tetrabenazine can be decreased when combined with Methimazole.
Ertugliflozin Ertugliflozin Ertugliflozin may increase the excretion rate of Methimazole which could result in a lower serum level and potentially a reduction in efficacy.
Buprenorphine Injection Buprenorphine Injection The metabolism of Buprenorphine can be decreased when combined with Methimazole.
Apalutamide Apalutamide The metabolism of Apalutamide can be decreased when combined with Methimazole.
Penicillamine Penicillamine The risk or severity of adverse effects can be increased when Methimazole is combined with Penicillamine.
Fostamatinib Fostamatinib The therapeutic efficacy of Methimazole can be decreased when used in combination with Fostamatinib.
Baricitinib Baricitinib The metabolism of Baricitinib can be decreased when combined with Methimazole.
Lofexidine Lofexidine The metabolism of Lofexidine can be decreased when combined with Methimazole.
Plazomicin Injection Plazomicin Injection Methimazole may decrease the excretion rate of Plazomicin which could result in a higher serum level.
Eliglustat Eliglustat The metabolism of Eliglustat can be decreased when combined with Methimazole.
Encorafenib Encorafenib The metabolism of Encorafenib can be decreased when combined with Methimazole.
Binimetinib Binimetinib The metabolism of Binimetinib can be decreased when combined with Methimazole.
Ivosidenib Ivosidenib The metabolism of Ivosidenib can be decreased when combined with Methimazole.
Elagolix Elagolix The metabolism of Elagolix can be decreased when combined with Methimazole.
Tafenoquine Tafenoquine The metabolism of Tafenoquine can be decreased when combined with Methimazole.
Cannabidiol Cannabidiol The metabolism of Cannabidiol can be decreased when combined with Methimazole.
Dacomitinib Dacomitinib The therapeutic efficacy of Methimazole can be decreased when used in combination with Dacomitinib.
Duvelisib Duvelisib The metabolism of Duvelisib can be decreased when combined with Methimazole.
Stiripentol Stiripentol The metabolism of Stiripentol can be decreased when combined with Methimazole.
Gilteritinib Gilteritinib The therapeutic efficacy of Methimazole can be decreased when used in combination with Gilteritinib.
Lorlatinib Lorlatinib The metabolism of Lorlatinib can be decreased when combined with Methimazole.
Larotrectinib Larotrectinib The therapeutic efficacy of Methimazole can be decreased when used in combination with Larotrectinib.
Paclitaxel (with albumin) Injection Paclitaxel (with albumin) Injection The metabolism of Paclitaxel can be decreased when combined with Methimazole.
Prucalopride Prucalopride The metabolism of Prucalopride can be decreased when combined with Methimazole.
Ravulizumab-cwvz Injection Ravulizumab-cwvz Injection The risk or severity of adverse effects can be increased when Methimazole is combined with Ravulizumab.
Emapalumab-lzsg Injection Emapalumab-lzsg Injection The risk or severity of adverse effects can be increased when Methimazole is combined with Emapalumab.
Siponimod Siponimod The risk or severity of adverse effects can be increased when Methimazole is combined with Siponimod.
Acyclovir Ophthalmic Acyclovir Ophthalmic Acyclovir may decrease the excretion rate of Methimazole which could result in a higher serum level.
Caplacizumab-yhdp Injection Caplacizumab-yhdp Injection The risk or severity of bleeding can be increased when Caplacizumab is combined with Methimazole.
Erdafitinib Erdafitinib The metabolism of Erdafitinib can be decreased when combined with Methimazole.
Esomeprazole Injection Esomeprazole Injection The metabolism of Esomeprazole can be decreased when combined with Methimazole.
Risankizumab-rzaa Injection Risankizumab-rzaa Injection The risk or severity of adverse effects can be increased when Methimazole is combined with Risankizumab.
Alpelisib Alpelisib The metabolism of Alpelisib can be decreased when combined with Methimazole.
Cladribine Cladribine The risk or severity of adverse effects can be increased when Cladribine is combined with Methimazole.
Polatuzumab vedotin-piiq Injection Polatuzumab vedotin-piiq Injection The risk or severity of adverse effects can be increased when Methimazole is combined with Polatuzumab vedotin.
Solriamfetol Solriamfetol Methimazole may decrease the excretion rate of Solriamfetol which could result in a higher serum level.
Darolutamide Darolutamide The serum concentration of Darolutamide can be increased when it is combined with Methimazole.
Triclabendazole Triclabendazole The metabolism of Triclabendazole can be decreased when combined with Methimazole.
Entrectinib Entrectinib The metabolism of Methimazole can be decreased when combined with Entrectinib.
Pexidartinib Pexidartinib The metabolism of Methimazole can be decreased when combined with Pexidartinib.
Upadacitinib Upadacitinib The metabolism of Upadacitinib can be decreased when combined with Methimazole.
Istradefylline Istradefylline The metabolism of Istradefylline can be decreased when combined with Methimazole.
Pitolisant Pitolisant The metabolism of Pitolisant can be decreased when combined with Methimazole.
Pretomanid Pretomanid The serum concentration of Pretomanid can be increased when it is combined with Methimazole.
Fedratinib Fedratinib The therapeutic efficacy of Fedratinib can be decreased when used in combination with Methimazole.
Lefamulin Lefamulin The serum concentration of Lefamulin can be increased when it is combined with Methimazole.
Phenytoin Injection Phenytoin Injection The metabolism of Phenytoin can be decreased when combined with Methimazole.
Fosphenytoin Injection Fosphenytoin Injection The metabolism of Fosphenytoin can be decreased when combined with Methimazole.
Enfortumab vedotin-ejfv Injection Enfortumab vedotin-ejfv Injection The serum concentration of Enfortumab vedotin can be increased when it is combined with Methimazole.
Zanubrutinib Zanubrutinib The metabolism of Zanubrutinib can be decreased when combined with Methimazole.
Voxelotor Voxelotor The serum concentration of Voxelotor can be increased when it is combined with Methimazole.
Avapritinib Avapritinib The metabolism of Avapritinib can be decreased when combined with Methimazole.
Lumateperone Lumateperone The serum concentration of Lumateperone can be increased when it is combined with Methimazole.
Ubrogepant Ubrogepant The serum concentration of Ubrogepant can be increased when it is combined with Methimazole.
Tazemetostat Tazemetostat The metabolism of Tazemetostat can be decreased when combined with Methimazole.
Cenobamate Cenobamate The metabolism of Cenobamate can be decreased when combined with Methimazole.
Pemigatinib Pemigatinib The metabolism of Pemigatinib can be decreased when combined with Methimazole.
Ozanimod Ozanimod The risk or severity of adverse effects can be increased when Methimazole is combined with Ozanimod.
Selumetinib Selumetinib The serum concentration of Methimazole can be increased when it is combined with Selumetinib.
Rimegepant Rimegepant The metabolism of Rimegepant can be decreased when combined with Methimazole.
Tucatinib Tucatinib The therapeutic efficacy of Methimazole can be decreased when used in combination with Tucatinib.
Ripretinib Ripretinib The serum concentration of Ripretinib can be increased when it is combined with Methimazole.
Selpercatinib Selpercatinib The therapeutic efficacy of Methimazole can be decreased when used in combination with Selpercatinib.
Capmatinib Capmatinib The therapeutic efficacy of Methimazole can be decreased when used in combination with Capmatinib.
Lurbinectedin Injection Lurbinectedin Injection The serum concentration of Lurbinectedin can be increased when it is combined with Methimazole.
Pralsetinib Pralsetinib The serum concentration of Pralsetinib can be increased when it is combined with Methimazole.
Progestin-Only (drospirenone) Oral Contraceptives Progestin-Only (drospirenone) Oral Contraceptives The metabolism of Methimazole can be decreased when combined with Drospirenone.
Viloxazine Viloxazine Methimazole may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Tobramycin Injection Tobramycin Injection Tobramycin may decrease the excretion rate of Methimazole which could result in a higher serum level.
Theophylline Theophylline The excretion of Theophylline can be decreased when combined with Methimazole.
Fenoprofen Fenoprofen Fenoprofen may decrease the excretion rate of Methimazole which could result in a higher serum level.
Indomethacin Indomethacin The risk or severity of adverse effects can be increased when Indomethacin is combined with Methimazole.
Mefenamic Acid Mefenamic Acid Mefenamic acid may decrease the excretion rate of Methimazole which could result in a higher serum level.
Naproxen Naproxen Naproxen may decrease the excretion rate of Methimazole which could result in a higher serum level.
Tolmetin Tolmetin Tolmetin may decrease the excretion rate of Methimazole which could result in a higher serum level.
Sulindac Sulindac Sulindac may decrease the excretion rate of Methimazole which could result in a higher serum level.
Trazodone Trazodone The serum concentration of Trazodone can be increased when it is combined with Methimazole.
Isotretinoin Isotretinoin Methimazole may decrease the excretion rate of Isotretinoin which could result in a higher serum level.
Sucralfate Sucralfate Sucralfate may decrease the excretion rate of Methimazole which could result in a higher serum level.
Hydroxyurea Hydroxyurea The risk or severity of adverse effects can be increased when Methimazole is combined with Hydroxyurea.
Floxuridine Floxuridine The risk or severity of adverse effects can be increased when Floxuridine is combined with Methimazole.
Phenobarbital Phenobarbital The metabolism of Phenobarbital can be decreased when combined with Methimazole.
Metaxalone Metaxalone Metaxalone may decrease the excretion rate of Methimazole which could result in a higher serum level.
Methotrexate Injection Methotrexate Injection The metabolism of Methimazole can be decreased when combined with Methotrexate.
Primidone Primidone The metabolism of Primidone can be decreased when combined with Methimazole.
Methsuximide Methsuximide The metabolism of Methsuximide can be decreased when combined with Methimazole.
Diethylpropion Diethylpropion The risk or severity of adverse effects can be increased when Diethylpropion is combined with Methimazole.
Chlorpromazine Chlorpromazine The metabolism of Chlorpromazine can be decreased when combined with Methimazole.
Diazepam Diazepam The metabolism of Diazepam can be decreased when combined with Methimazole.
Oxazepam Oxazepam Methimazole may decrease the excretion rate of Oxazepam which could result in a higher serum level.
Flurazepam Flurazepam Methimazole may decrease the excretion rate of Flurazepam which could result in a higher serum level.
Clorazepate Clorazepate Clorazepic acid may decrease the excretion rate of Methimazole which could result in a higher serum level.
Lorazepam Lorazepam The metabolism of Methimazole can be decreased when combined with Lorazepam.
Carmustine Carmustine The risk or severity of adverse effects can be increased when Carmustine is combined with Methimazole.
Amantadine Amantadine Methimazole may decrease the excretion rate of Amantadine which could result in a higher serum level.
Codeine Codeine The metabolism of Methimazole can be decreased when combined with Codeine.
Metaproterenol Metaproterenol The risk or severity of adverse effects can be increased when Orciprenaline is combined with Methimazole.
Phenelzine Phenelzine Methimazole may decrease the excretion rate of Phenelzine which could result in a higher serum level.
Procarbazine Procarbazine The risk or severity of adverse effects can be increased when Methimazole is combined with Procarbazine.
Tetracycline Tetracycline Tetracycline may decrease the excretion rate of Methimazole which could result in a higher serum level.
Thioguanine Thioguanine The risk or severity of adverse effects can be increased when Tioguanine is combined with Methimazole.
Prochlorperazine Prochlorperazine The metabolism of Prochlorperazine can be decreased when combined with Methimazole.
Thioridazine Thioridazine The metabolism of Thioridazine can be decreased when combined with Methimazole.
Trifluoperazine Trifluoperazine The metabolism of Trifluoperazine can be decreased when combined with Methimazole.
Bleomycin Bleomycin The risk or severity of adverse effects can be increased when Bleomycin is combined with Methimazole.
Dapsone Dapsone The metabolism of Dapsone can be decreased when combined with Methimazole.
Sulfadiazine Sulfadiazine Sulfadiazine may decrease the excretion rate of Methimazole which could result in a higher serum level.
Oxycodone Oxycodone The metabolism of Oxycodone can be decreased when combined with Methimazole.
Methadone Methadone The metabolism of Methadone can be decreased when combined with Methimazole.
Benztropine Benztropine The metabolism of Methimazole can be decreased when combined with Benzatropine.
Maprotiline Maprotiline The metabolism of Maprotiline can be decreased when combined with Methimazole.
Ibuprofen Ibuprofen The metabolism of Ibuprofen can be decreased when combined with Methimazole.
Perphenazine Perphenazine The metabolism of Perphenazine can be decreased when combined with Methimazole.
Azathioprine Azathioprine The risk or severity of adverse effects can be increased when Methimazole is combined with Azathioprine.
Phentermine Phentermine The metabolism of Methimazole can be decreased when combined with Phentermine.
Methylphenidate Methylphenidate Methylphenidate may decrease the excretion rate of Methimazole which could result in a higher serum level.
Amoxapine Amoxapine The risk or severity of Cardiac Arrhythmia can be increased when Methimazole is combined with Amoxapine.
Sulfasalazine Sulfasalazine The risk or severity of adverse effects can be increased when Methimazole is combined with Sulfasalazine.
Hydrocortisone Hydrocortisone The metabolism of Hydrocortisone can be decreased when combined with Methimazole.
Lomustine Lomustine The risk or severity of adverse effects can be increased when Methimazole is combined with Lomustine.
Doxorubicin Doxorubicin The metabolism of Doxorubicin can be decreased when combined with Methimazole.
Cytarabine Cytarabine The risk or severity of adverse effects can be increased when Methimazole is combined with Cytarabine.
Mechlorethamine Mechlorethamine The risk or severity of adverse effects can be increased when Methimazole is combined with Mechlorethamine.
Dactinomycin Dactinomycin The risk or severity of adverse effects can be increased when Methimazole is combined with Dactinomycin.
Phenazopyridine Phenazopyridine Phenazopyridine may decrease the excretion rate of Methimazole which could result in a higher serum level.
Carbamazepine Carbamazepine The metabolism of Carbamazepine can be decreased when combined with Methimazole.
Methyldopa Methyldopa Methimazole may decrease the excretion rate of Methyldopa which could result in a higher serum level.
Clonidine Clonidine The metabolism of Clonidine can be decreased when combined with Methimazole.
Hydralazine Hydralazine Methimazole may decrease the excretion rate of Hydralazine which could result in a higher serum level.
Cimetidine Cimetidine Cimetidine may decrease the excretion rate of Methimazole which could result in a higher serum level.
Gentamicin Injection Gentamicin Injection Gentamicin may decrease the excretion rate of Methimazole which could result in a higher serum level.
Warfarin Warfarin Methimazole may decrease the anticoagulant activities of Warfarin.
Clonazepam Clonazepam Methimazole may decrease the excretion rate of Clonazepam which could result in a higher serum level.
Loperamide Loperamide The metabolism of Loperamide can be decreased when combined with Methimazole.
Promethazine Promethazine The metabolism of Promethazine can be decreased when combined with Methimazole.
Meclofenamate Meclofenamate Meclofenamic acid may decrease the excretion rate of Methimazole which could result in a higher serum level.
Daunorubicin Daunorubicin The risk or severity of adverse effects can be increased when Daunorubicin is combined with Methimazole.
Nitrofurantoin Nitrofurantoin Nitrofurantoin may decrease the excretion rate of Methimazole which could result in a higher serum level.
Digoxin Digoxin The serum concentration of Digoxin can be increased when it is combined with Methimazole.
Chloroquine Chloroquine The metabolism of Chloroquine can be decreased when combined with Methimazole.
Quinine Quinine The metabolism of Quinine can be decreased when combined with Methimazole.
Ethosuximide Ethosuximide The metabolism of Ethosuximide can be decreased when combined with Methimazole.
Triamterene Triamterene The metabolism of Triamterene can be decreased when combined with Methimazole.
Sulfinpyrazone Sulfinpyrazone The risk or severity of bleeding can be increased when Sulfinpyrazone is combined with Methimazole.
Chlorothiazide Chlorothiazide Chlorothiazide may increase the excretion rate of Methimazole which could result in a lower serum level and potentially a reduction in efficacy.
Chlorthalidone Chlorthalidone Chlorthalidone may increase the excretion rate of Methimazole which could result in a lower serum level and potentially a reduction in efficacy.
Metolazone Metolazone Metolazone may increase the excretion rate of Methimazole which could result in a lower serum level and potentially a reduction in efficacy.
Isosorbide Isosorbide Isosorbide may increase the excretion rate of Methimazole which could result in a lower serum level and potentially a reduction in efficacy.
Secobarbital Secobarbital Secobarbital may decrease the excretion rate of Methimazole which could result in a higher serum level.
Desipramine Desipramine The risk or severity of Cardiac Arrhythmia can be increased when Methimazole is combined with Desipramine.
Amitriptyline Amitriptyline The metabolism of Amitriptyline can be decreased when combined with Methimazole.
Imipramine Imipramine The risk or severity of Cardiac Arrhythmia can be increased when Methimazole is combined with Imipramine.
Probenecid Probenecid Methimazole may decrease the excretion rate of Probenecid which could result in a higher serum level.
Quinidine Quinidine The metabolism of Quinidine can be decreased when combined with Methimazole.
Procainamide Procainamide The metabolism of Procainamide can be decreased when combined with Methimazole.
Isoniazid Isoniazid Methimazole may decrease the excretion rate of Isoniazid which could result in a higher serum level.
Pyrazinamide Pyrazinamide Pyrazinamide may decrease the excretion rate of Methimazole which could result in a higher serum level.
Disopyramide Disopyramide The metabolism of Disopyramide can be decreased when combined with Methimazole.
Valproic Acid Valproic Acid The metabolism of Valproic acid can be decreased when combined with Methimazole.
Tamoxifen Tamoxifen The metabolism of Tamoxifen can be decreased when combined with Methimazole.
Mitomycin Mitomycin The risk or severity of adverse effects can be increased when Mitomycin is combined with Methimazole.
Butabarbital Butabarbital Butabarbital may decrease the excretion rate of Methimazole which could result in a higher serum level.
Liothyronine Liothyronine Liothyronine may decrease the excretion rate of Methimazole which could result in a higher serum level.
Propylthiouracil Propylthiouracil The risk or severity of adverse effects can be increased when Propylthiouracil is combined with Methimazole.
Chlorpropamide Chlorpropamide The therapeutic efficacy of Chlorpropamide can be decreased when used in combination with Methimazole.
Tolbutamide Tolbutamide The therapeutic efficacy of Tolbutamide can be decreased when used in combination with Methimazole.
Tolazamide Tolazamide The therapeutic efficacy of Tolazamide can be decreased when used in combination with Methimazole.
Dextromethorphan Dextromethorphan The metabolism of Dextromethorphan can be decreased when combined with Methimazole.
Cyclobenzaprine Cyclobenzaprine The metabolism of Cyclobenzaprine can be decreased when combined with Methimazole.
Baclofen Baclofen Baclofen may decrease the excretion rate of Methimazole which could result in a higher serum level.
Chlorpheniramine Chlorpheniramine The metabolism of Chlorpheniramine can be decreased when combined with Methimazole.
Brompheniramine Brompheniramine The metabolism of Brompheniramine can be decreased when combined with Methimazole.
Meclizine Meclizine The metabolism of Meclizine can be decreased when combined with Methimazole.
Ethambutol Ethambutol Ethambutol may decrease the excretion rate of Methimazole which could result in a higher serum level.
Methyclothiazide Methyclothiazide Methyclothiazide may increase the excretion rate of Methimazole which could result in a lower serum level and potentially a reduction in efficacy.
Hydrochlorothiazide Hydrochlorothiazide Hydrochlorothiazide may decrease the excretion rate of Methimazole which could result in a higher serum level.
Chlorzoxazone Chlorzoxazone The metabolism of Chlorzoxazone can be decreased when combined with Methimazole.
Carisoprodol Carisoprodol The metabolism of Carisoprodol can be decreased when combined with Methimazole.
Pyridoxine Pyridoxine Pyridoxine may decrease the excretion rate of Methimazole which could result in a higher serum level.
Folic Acid Folic Acid Folic acid may decrease the excretion rate of Methimazole which could result in a higher serum level.
Propranolol (Cardiovascular) Propranolol (Cardiovascular) The excretion of Propranolol can be decreased when combined with Methimazole.
Pseudoephedrine Pseudoephedrine The risk or severity of adverse effects can be increased when Pseudoephedrine is combined with Methimazole.
Nortriptyline Nortriptyline The risk or severity of Cardiac Arrhythmia can be increased when Methimazole is combined with Nortriptyline.
Spironolactone Spironolactone Spironolactone may increase the excretion rate of Methimazole which could result in a lower serum level and potentially a reduction in efficacy.
Amphotericin B Injection Amphotericin B Injection Amphotericin B may decrease the excretion rate of Methimazole which could result in a higher serum level.
Mercaptopurine Mercaptopurine Methimazole may decrease the excretion rate of Mercaptopurine which could result in a higher serum level.
Phytonadione Phytonadione Methimazole may decrease the excretion rate of Phylloquinone which could result in a higher serum level.
Amikacin Injection Amikacin Injection Amikacin may decrease the excretion rate of Methimazole which could result in a higher serum level.
Nadolol Nadolol The excretion of Nadolol can be decreased when combined with Methimazole.
Allopurinol Allopurinol The risk or severity of adverse effects can be increased when Allopurinol is combined with Methimazole.
Flavoxate Flavoxate Methimazole may decrease the excretion rate of Flavoxate which could result in a higher serum level.
Fluorouracil Injection Fluorouracil Injection The metabolism of Methimazole can be decreased when combined with Fluorouracil.
Colchicine Colchicine The metabolism of Colchicine can be decreased when combined with Methimazole.
Cefaclor Cefaclor Cefaclor may decrease the excretion rate of Methimazole which could result in a higher serum level.
Cefadroxil Cefadroxil Cefadroxil may decrease the excretion rate of Methimazole which could result in a higher serum level.
Cefazolin Injection Cefazolin Injection Cefazolin may decrease the excretion rate of Methimazole which could result in a higher serum level.
Cephalexin Cephalexin The metabolism of Methimazole can be decreased when combined with Cephalexin.
Cefoxitin Injection Cefoxitin Injection Cefoxitin may decrease the excretion rate of Methimazole which could result in a higher serum level.
Dacarbazine Dacarbazine The risk or severity of adverse effects can be increased when Methimazole is combined with Dacarbazine.
Acetazolamide Acetazolamide Acetazolamide may increase the excretion rate of Methimazole which could result in a lower serum level and potentially a reduction in efficacy.
Cefotaxime Injection Cefotaxime Injection Cefotaxime may decrease the excretion rate of Methimazole which could result in a higher serum level.
Calcitonin Salmon Injection Calcitonin Salmon Injection Salmon calcitonin may decrease the excretion rate of Methimazole which could result in a higher serum level.
Bacillus Calmette-Guerin (BCG) Vaccine Bacillus Calmette-Guerin (BCG) Vaccine The risk or severity of infection can be increased when Bacillus calmette-guerin substrain tice live antigen is combined with Methimazole.
Pyrantel Pyrantel Methimazole may decrease the excretion rate of Pyrantel which could result in a higher serum level.
Thiotepa Injection Thiotepa Injection The metabolism of Thiotepa can be decreased when combined with Methimazole.
Vincristine Injection Vincristine Injection The metabolism of Methimazole can be decreased when combined with Vincristine.
Dipyridamole Dipyridamole Methimazole may increase the anticoagulant activities of Dipyridamole.
Isoxsuprine Isoxsuprine The risk or severity of adverse effects can be increased when Isoxsuprine is combined with Methimazole.
Vinblastine Vinblastine The metabolism of Methimazole can be decreased when combined with Vinblastine.
Ethacrynic Acid Ethacrynic Acid Etacrynic acid may decrease the excretion rate of Methimazole which could result in a higher serum level.
Colistimethate Injection Colistimethate Injection Colistimethate may decrease the excretion rate of Methimazole which could result in a higher serum level.
Metoprolol Metoprolol The excretion of Methimazole can be decreased when combined with Metoprolol.
Thiothixene Thiothixene The metabolism of Thiothixene can be decreased when combined with Methimazole.
Aspirin Aspirin Acetylsalicylic acid may decrease the excretion rate of Methimazole which could result in a higher serum level.
Salsalate Salsalate Salsalate may decrease the excretion rate of Methimazole which could result in a higher serum level.
Chlorambucil Chlorambucil The risk or severity of adverse effects can be increased when Chlorambucil is combined with Methimazole.
Alprazolam Alprazolam The metabolism of Alprazolam can be decreased when combined with Methimazole.
Temazepam Temazepam Temazepam may decrease the excretion rate of Methimazole which could result in a higher serum level.
Triazolam Triazolam Methimazole may decrease the excretion rate of Triazolam which could result in a higher serum level.
Dicyclomine Dicyclomine Methimazole may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Propantheline Propantheline Methimazole may decrease the excretion rate of Propantheline which could result in a higher serum level.
Trimethoprim Trimethoprim The metabolism of Trimethoprim can be decreased when combined with Methimazole.
Diltiazem Diltiazem The metabolism of Diltiazem can be decreased when combined with Methimazole.
Nifedipine Nifedipine The metabolism of Nifedipine can be decreased when combined with Methimazole.
Timolol Timolol The metabolism of Timolol can be decreased when combined with Methimazole.
Verapamil Verapamil The metabolism of Verapamil can be decreased when combined with Methimazole.
Atenolol Atenolol The excretion of Atenolol can be decreased when combined with Methimazole.
Pindolol Pindolol The excretion of Pindolol can be decreased when combined with Methimazole.
Cisplatin Injection Cisplatin Injection The risk or severity of adverse effects can be increased when Cisplatin is combined with Methimazole.
Diflunisal Diflunisal Diflunisal may decrease the excretion rate of Methimazole which could result in a higher serum level.
Piroxicam Piroxicam Piroxicam may decrease the excretion rate of Methimazole which could result in a higher serum level.
Bumetanide Bumetanide Methimazole may increase the excretion rate of Bumetanide which could result in a lower serum level and potentially a reduction in efficacy.
Streptozocin Streptozocin The risk or severity of adverse effects can be increased when Streptozocin is combined with Methimazole.
Etoposide Etoposide The metabolism of Etoposide can be decreased when combined with Methimazole.
Glyburide Glyburide The therapeutic efficacy of Glyburide can be decreased when used in combination with Methimazole.
Glipizide Glipizide The therapeutic efficacy of Glipizide can be decreased when used in combination with Methimazole.
Indapamide Indapamide Indapamide may increase the excretion rate of Methimazole which could result in a lower serum level and potentially a reduction in efficacy.
Amoxicillin Amoxicillin Methimazole may decrease the excretion rate of Amoxicillin which could result in a higher serum level.
Oxacillin Injection Oxacillin Injection Oxacillin may decrease the excretion rate of Methimazole which could result in a higher serum level.
Pentoxifylline Pentoxifylline Methimazole may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.
Pentamidine Injection Pentamidine Injection Pentamidine may decrease the excretion rate of Methimazole which could result in a higher serum level.
Ceftriaxone Injection Ceftriaxone Injection Ceftriaxone may decrease the excretion rate of Methimazole which could result in a higher serum level.
Labetalol Labetalol The excretion of Methimazole can be decreased when combined with Labetalol.
Auranofin Auranofin Methimazole may decrease the excretion rate of Auranofin which could result in a higher serum level.
Leuprolide Injection Leuprolide Injection Leuprolide may decrease the excretion rate of Methimazole which could result in a higher serum level.
Gemfibrozil Gemfibrozil Methimazole may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.
Guanabenz Guanabenz The metabolism of Guanabenz can be decreased when combined with Methimazole.
Dipivefrin Ophthalmic Dipivefrin Ophthalmic Adefovir dipivoxil may decrease the excretion rate of Methimazole which could result in a higher serum level.
Ceftazidime Injection Ceftazidime Injection Ceftazidime may decrease the excretion rate of Methimazole which could result in a higher serum level.
Ketoprofen Ketoprofen Ketoprofen may decrease the excretion rate of Methimazole which could result in a higher serum level.
Cefotetan Injection Cefotetan Injection Cefotetan may decrease the excretion rate of Methimazole which could result in a higher serum level.
Pimozide Pimozide The metabolism of Pimozide can be decreased when combined with Methimazole.
Flurbiprofen Flurbiprofen Flurbiprofen may decrease the excretion rate of Methimazole which could result in a higher serum level.
Amiodarone Amiodarone The therapeutic efficacy of Methimazole can be decreased when used in combination with Amiodarone.
Aztreonam Injection Aztreonam Injection Aztreonam may decrease the excretion rate of Methimazole which could result in a higher serum level.
Buspirone Buspirone The metabolism of Buspirone can be decreased when combined with Methimazole.
Lovastatin Lovastatin The serum concentration of Lovastatin can be increased when it is combined with Methimazole.
Ciprofloxacin Ciprofloxacin Ciprofloxacin may decrease the excretion rate of Methimazole which could result in a higher serum level.
Mesalamine Mesalamine Mesalazine may decrease the excretion rate of Methimazole which could result in a higher serum level.
Diclofenac Diclofenac The metabolism of Diclofenac can be decreased when combined with Methimazole.
Fluoxetine Fluoxetine The metabolism of Fluoxetine can be decreased when combined with Methimazole.
Interferon Alfa-2b Injection Interferon Alfa-2b Injection The risk or severity of adverse effects can be increased when Interferon alfa-2b is combined with Methimazole.
Clozapine Clozapine The risk or severity of neutropenia can be increased when Methimazole is combined with Clozapine.
Estazolam Estazolam Methimazole may decrease the excretion rate of Estazolam which could result in a higher serum level.
Idarubicin Idarubicin The risk or severity of adverse effects can be increased when Methimazole is combined with Idarubicin.
Didanosine Didanosine Methimazole may decrease the excretion rate of Didanosine which could result in a higher serum level.
Fludarabine Injection Fludarabine Injection The risk or severity of adverse effects can be increased when Methimazole is combined with Fludarabine.
Pentostatin Injection Pentostatin Injection The risk or severity of adverse effects can be increased when Pentostatin is combined with Methimazole.
Etodolac Etodolac Etodolac may decrease the excretion rate of Methimazole which could result in a higher serum level.
Fosinopril Fosinopril Fosinopril may decrease the excretion rate of Methimazole which could result in a higher serum level.
Nabumetone Nabumetone Nabumetone may decrease the excretion rate of Methimazole which could result in a higher serum level.
Simvastatin Simvastatin The metabolism of Simvastatin can be decreased when combined with Methimazole.
Amlodipine Amlodipine The metabolism of Amlodipine can be decreased when combined with Methimazole.
Teniposide Injection Teniposide Injection The metabolism of Methimazole can be decreased when combined with Teniposide.
Lisinopril Lisinopril Lisinopril may decrease the excretion rate of Methimazole which could result in a higher serum level.
Oxaprozin Oxaprozin Oxaprozin may decrease the excretion rate of Methimazole which could result in a higher serum level.
Sotalol Sotalol The excretion of Sotalol can be decreased when combined with Methimazole.
Bisoprolol Bisoprolol The excretion of Methimazole can be decreased when combined with Bisoprolol.
Zolpidem Zolpidem The metabolism of Zolpidem can be decreased when combined with Methimazole.
Doxazosin Doxazosin The metabolism of Doxazosin can be decreased when combined with Methimazole.
Isradipine Isradipine Isradipine may decrease the excretion rate of Methimazole which could result in a higher serum level.
Omeprazole Omeprazole The metabolism of Omeprazole can be decreased when combined with Methimazole.
Cisapride Cisapride The metabolism of Cisapride can be decreased when combined with Methimazole.
Fluvastatin Fluvastatin The metabolism of Fluvastatin can be decreased when combined with Methimazole.
Venlafaxine Venlafaxine The metabolism of Venlafaxine can be decreased when combined with Methimazole.
Famciclovir Famciclovir The metabolism of Famciclovir can be decreased when combined with Methimazole.
Fluvoxamine Fluvoxamine The metabolism of Fluvoxamine can be decreased when combined with Methimazole.
Nefazodone Nefazodone The metabolism of Nefazodone can be decreased when combined with Methimazole.
Lamotrigine Lamotrigine Lamotrigine may decrease the excretion rate of Methimazole which could result in a higher serum level.
Losartan Losartan The metabolism of Losartan can be decreased when combined with Methimazole.
Valacyclovir Valacyclovir Valaciclovir may decrease the excretion rate of Methimazole which could result in a higher serum level.
Tramadol Tramadol The metabolism of Tramadol can be decreased when combined with Methimazole.
Vinorelbine Injection Vinorelbine Injection The metabolism of Methimazole can be decreased when combined with Vinorelbine.
Carboplatin Injection Carboplatin Injection The risk or severity of adverse effects can be increased when Methimazole is combined with Carboplatin.
Lansoprazole Lansoprazole The metabolism of Lansoprazole can be decreased when combined with Methimazole.
Ifosfamide Injection Ifosfamide Injection The metabolism of Ifosfamide can be decreased when combined with Methimazole.
Pegaspargase Injection Pegaspargase Injection The risk or severity of adverse effects can be increased when Pegaspargase is combined with Methimazole.
Bupropion Bupropion The serum concentration of Bupropion can be increased when it is combined with Methimazole.
Ticlopidine Ticlopidine The metabolism of Methimazole can be decreased when combined with Ticlopidine.
Metformin Metformin Metformin may decrease the excretion rate of Methimazole which could result in a higher serum level.
Dalteparin Injection Dalteparin Injection Methimazole may increase the anticoagulant activities of Dalteparin.
Nisoldipine Nisoldipine Nisoldipine may decrease the excretion rate of Methimazole which could result in a higher serum level.
Lamivudine Lamivudine Lamivudine may decrease the excretion rate of Methimazole which could result in a higher serum level.
Riluzole Riluzole The metabolism of Riluzole can be decreased when combined with Methimazole.
Acarbose Acarbose Acarbose may decrease the excretion rate of Methimazole which could result in a higher serum level.
Glimepiride Glimepiride The therapeutic efficacy of Glimepiride can be decreased when used in combination with Methimazole.
Gemcitabine Injection Gemcitabine Injection The risk or severity of adverse effects can be increased when Gemcitabine is combined with Methimazole.
Ritonavir Ritonavir The metabolism of Ritonavir can be decreased when combined with Methimazole.
Docetaxel Injection Docetaxel Injection The metabolism of Docetaxel can be decreased when combined with Methimazole.
Cidofovir Injection Cidofovir Injection Cidofovir may decrease the excretion rate of Methimazole which could result in a higher serum level.
Meropenem Injection Meropenem Injection Meropenem may decrease the excretion rate of Methimazole which could result in a higher serum level.
Clomipramine Clomipramine The risk or severity of Cardiac Arrhythmia can be increased when Methimazole is combined with Clomipramine.
Zafirlukast Zafirlukast The metabolism of Zafirlukast can be decreased when combined with Methimazole.
Fosfomycin Fosfomycin Methimazole may decrease the excretion rate of Fosfomycin which could result in a higher serum level.
Mirtazapine Mirtazapine The metabolism of Mirtazapine can be decreased when combined with Methimazole.
Topiramate Topiramate Topiramate may decrease the excretion rate of Methimazole which could result in a higher serum level.
Zileuton Zileuton The metabolism of Zileuton can be decreased when combined with Methimazole.
Valsartan Valsartan The metabolism of Valsartan can be decreased when combined with Methimazole.
Pramipexole Pramipexole Pramipexole may decrease the excretion rate of Methimazole which could result in a higher serum level.
Donepezil Donepezil The metabolism of Donepezil can be decreased when combined with Methimazole.
Azithromycin Azithromycin The metabolism of Azithromycin can be decreased when combined with Methimazole.
Carvedilol Carvedilol The excretion of Carvedilol can be decreased when combined with Methimazole.
Nilutamide Nilutamide Nilutamide may decrease the excretion rate of Methimazole which could result in a higher serum level.
Flutamide Flutamide The metabolism of Flutamide can be decreased when combined with Methimazole.
Selegiline Selegiline The metabolism of Selegiline can be decreased when combined with Methimazole.
Bicalutamide Bicalutamide The metabolism of Bicalutamide can be decreased when combined with Methimazole.
Sertraline Sertraline The metabolism of Methimazole can be decreased when combined with Sertraline.
Propafenone Propafenone The excretion of Propafenone can be decreased when combined with Methimazole.
Letrozole Letrozole The metabolism of Letrozole can be decreased when combined with Methimazole.
Irbesartan Irbesartan The metabolism of Irbesartan can be decreased when combined with Methimazole.
Tamsulosin Tamsulosin The metabolism of Tamsulosin can be decreased when combined with Methimazole.
Ropinirole Ropinirole The risk or severity of adverse effects can be increased when Methimazole is combined with Ropinirole.
Quetiapine Quetiapine The serum concentration of Quetiapine can be increased when it is combined with Methimazole.
Cefepime Injection Cefepime Injection Cefepime may decrease the excretion rate of Methimazole which could result in a higher serum level.
Cefprozil Cefprozil Cefprozil may decrease the excretion rate of Methimazole which could result in a higher serum level.
Cefpodoxime Cefpodoxime Cefpodoxime may decrease the excretion rate of Methimazole which could result in a higher serum level.
Cetirizine Cetirizine Cetirizine may decrease the excretion rate of Methimazole which could result in a higher serum level.
Paroxetine Paroxetine The metabolism of Paroxetine can be decreased when combined with Methimazole.
Tolcapone Tolcapone Tolcapone may decrease the excretion rate of Methimazole which could result in a higher serum level.
Citalopram Citalopram Methimazole may increase the QTc-prolonging activities of Citalopram.
Capecitabine Capecitabine The metabolism of Capecitabine can be decreased when combined with Methimazole.
Efavirenz Efavirenz The metabolism of Efavirenz can be decreased when combined with Methimazole.
Abacavir Abacavir Methimazole may decrease the excretion rate of Abacavir which could result in a higher serum level.
Sildenafil Sildenafil The metabolism of Sildenafil can be decreased when combined with Methimazole.
Trastuzumab Injection Trastuzumab Injection Trastuzumab may increase the neutropenic activities of Methimazole.
Celecoxib Celecoxib The metabolism of Celecoxib can be decreased when combined with Methimazole.
Rosiglitazone Rosiglitazone The metabolism of Rosiglitazone can be decreased when combined with Methimazole.
Tolterodine Tolterodine The serum concentration of Tolterodine can be increased when it is combined with Methimazole.
Thalidomide Thalidomide The risk or severity of adverse effects can be increased when Methimazole is combined with Thalidomide.
Oseltamivir Oseltamivir Oseltamivir may decrease the excretion rate of Methimazole which could result in a higher serum level.
Balsalazide Balsalazide Balsalazide may decrease the excretion rate of Methimazole which could result in a higher serum level.
Nateglinide Nateglinide The metabolism of Nateglinide can be decreased when combined with Methimazole.
Galantamine Galantamine The metabolism of Galantamine can be decreased when combined with Methimazole.
Rabeprazole Rabeprazole The metabolism of Rabeprazole can be decreased when combined with Methimazole.
Terbinafine Terbinafine The metabolism of Terbinafine can be decreased when combined with Methimazole.

Content provided by: AHFS® Patient Medication Information™. © Copyright, 2021. The American Society of Health-System Pharmacists